Loading...
XJPX
4918
Market cap11mUSD
Oct 09, Last price  
325.00JPY
1D
9.43%
1Q
-3.85%
Jan 2017
-92.35%
Name

Ivy Cosmetics Corp

Chart & performance

D1W1MN
XJPX:4918 chart
P/E
12.41
P/S
0.77
EPS
26.18
Div yield, %
—
Shrs. gr., 5y
9.13%
Rev. gr., 5y
-5.07%
Revenues
2.64b
-9.84%
3,832,236,0003,426,764,0003,534,133,0002,942,229,0002,713,742,0002,929,931,0002,641,736,000
Net income
165m
+282.50%
45,906,000-23,228,00040,375,000-384,612,000160,311,00043,013,000164,525,000
CFO
451m
+1.14%
34,927,000427,020,000-107,064,000278,590,000453,061,000445,936,000451,036,000
Dividend
Mar 30, 202715 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emulsions, creams, and cleansing or face wash solutions. Additionally, the company provides specialized care treatments, makeup, hair care, and body care products, along with health foods and equipment, UV protection items, and a line of men's cosmetics. Established in 1975, the enterprise was initially known as Shirogane Corporation, adopting its current name, Ivy Cosmetics Corporation, in October 1977. The company's headquarters are located in Tokyo, Japan.

Key people

Kazunori Egawa
Manager of Corporate Planning, Director · since 2025
Seijin Nakayama
Director of Business Administration, Director · since 2022
Keishi Nakayama
Director · since 2022
Yu Nomoto
Director · since 2022
Emiko Shirogane
Chairman of the Board · since 1996
Koji Shirogane
President, Representative Director · since 2001
Kazuko Shirogane
Director · since 2021
Masakazu Tajima
Managing Director, Director of Product Planning · since 2022
Independent Director · since 2022
Tsukasa Wada
Independent Director · since 2022
IPO date
Apr 09, 1996
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT